miR-509-3p enhances platinum drug sensitivity in ovarian cancer
发布时间：2019-05-13 分享到：
… miRNA microarray system (Illumina) composed of probes targeting 2003 human miRNAs was employed to identify miRNA expression profile of platinum-sensitive and -resistant human ovarian cancers by Biomiao (Biomiao, China) according to product protocol …
上一篇：A functional copy-number variation in MAPKAPK2 predicts risk and prognosis of lung cancer
下一篇：Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene polymorphism and dental caries susceptibility in Chinese children
返回列表
相关推荐
- Increased osteogenesis in osteoporotic bone marrow stromal cells by ove2019-05-13
- Targeted P2X7R shRNA delivery attenuates sympathetic nerve sprouting an2019-05-13
- TNF-a (-238G/A and -308G/A) gene polymorphisms may not contribute to t2019-05-13
- Genetic polymorphisms in Sox17 associated with intracranial aneurysm in2019-05-13
- Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene poly2019-05-13
- miR-509-3p enhances platinum drug sensitivity in ovarian cancer2019-05-13